InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. The BUY prediction by BiotechBee for InVivo Therapeutics Holdings performed very badly with a performance of -46.57%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year